GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (HKSE:02196) » Definitions » Shiller PE Ratio

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Shiller PE Ratio : 13.62 (As of Apr. 26, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio?

As of today (2024-04-26), Shanghai Fosun Pharmaceutical (Group) Co's current share price is HK$12.26. Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Dec. 2023 was HK$0.90. Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is 13.62.

The historical rank and industry rank for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio or its related term are showing as below:

HKSE:02196' s Shiller PE Ratio Range Over the Past 10 Years
Min: 16.3   Med: 30.76   Max: 68.81
Current: 18.3

During the past years, Shanghai Fosun Pharmaceutical (Group) Co's highest Shiller PE Ratio was 68.81. The lowest was 16.30. And the median was 30.76.

HKSE:02196's Shiller PE Ratio is ranked better than
67.95% of 518 companies
in the Drug Manufacturers industry
Industry Median: 24.12 vs HKSE:02196: 18.30

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Dec. 2023 was HK$0.033. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is HK$0.90 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 25.06 47.03 38.38 26.21 18.96

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.21 23.77 22.91 21.05 18.96

Competitive Comparison of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio falls into.



Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=12.26/0.9
=13.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Fosun Pharmaceutical (Group) Co's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Shanghai Fosun Pharmaceutical (Group) Co's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.033/114.6694*114.6694
=0.033

Current CPI (Dec. 2023) = 114.6694.

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.239 98.600 0.278
201406 0.323 98.200 0.377
201409 0.303 98.900 0.351
201412 0.288 99.000 0.334
201503 0.286 99.900 0.328
201506 0.412 99.500 0.475
201509 0.304 100.500 0.347
201512 0.288 100.600 0.328
201603 0.322 102.200 0.361
201606 0.448 101.400 0.507
201609 0.337 102.400 0.377
201612 0.292 102.600 0.326
201703 0.349 103.200 0.388
201706 0.435 103.100 0.484
201709 0.345 104.100 0.380
201712 0.332 104.500 0.364
201803 0.348 105.300 0.379
201806 0.425 104.900 0.465
201809 0.229 106.600 0.246
201812 0.273 106.500 0.294
201903 0.327 107.700 0.348
201906 0.352 107.700 0.375
201909 0.242 109.800 0.253
201912 0.545 111.200 0.562
202003 0.254 112.300 0.259
202006 0.482 110.400 0.501
202009 0.341 111.700 0.350
202012 0.545 111.500 0.560
202103 0.394 112.662 0.401
202106 0.773 111.769 0.793
202109 0.506 112.215 0.517
202112 0.563 113.108 0.571
202203 0.222 114.335 0.223
202206 0.492 114.558 0.492
202209 0.380 115.339 0.378
202212 0.547 115.116 0.545
202303 0.421 115.116 0.419
202306 0.328 114.558 0.328
202309 0.193 115.339 0.192
202312 0.033 114.669 0.033

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Shanghai Fosun Pharmaceutical (Group) Co  (HKSE:02196) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Shanghai Fosun Pharmaceutical (Group) Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Business Description

Traded in Other Exchanges
Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is a specialty and generic drug manufacturing company. Shanghai Fosun maintains five business segments, including Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. Most of the company's revenue is generated by its Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Shanghai Fosun Pharmaceutical (Group) Co (HKSE:02196) Headlines

No Headlines